5 Results for "

AMI1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "AMI1" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-18962
CAS No.: 20324-87-2
Research Areas:  

Cancer

AMI-1 is a potent, cell-permeable and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM and 3.0 μM for human PRMT1 and yeast-Hmt1p, respectively. AMI-1 exerts PRMTs inhibitory effects by blocking peptide-substrate binding [1].
loading...
    loading...
7
7 Publications Verification
Cat. No.: HY-18962A
CAS No.: 134-47-4
Research Areas:  

Cancer

AMI-1 free acid is a potent, cell-permeable and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM and 3.0 μM for human PRMT1 and yeast-Hmt1p, respectively. AMI-1 free acid exerts PRMTs inhibitory effects by blocking peptide-substrate binding [1].
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-112205
CAS No.: 1361390-56-8
Purity:  81.51%
Target:  

Legumain

Research Areas:  

Cancer

RR-11a is a synthetic enzyme inhibitor of Legumain (IC50=31-55 nM). RR-11a can be used for the research of cancer and acute myocardial infarction (AMI) .
loading...
    loading...
Cat. No.: HY-18962R
CAS No.: 20324-87-2
Research Areas:  

Cancer

AMI-1 (Standard) is the analytical standard of AMI-1. This product is intended for research and analytical applications. AMI-1 is a potent, cell-permeable and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM and 3.0 μM for human PRMT1 and yeast-Hmt1p, respectively. AMI-1 exerts PRMTs inhibitory effects by blocking peptide-substrate binding [1].
loading...
    loading...
Cat. No.: HY-18962AR
CAS No.: 134-47-4
Research Areas:  

Cancer

AMI-1 (free acid) (Standard) is the analytical standard of AMI-1 (free acid). This product is intended for research and analytical applications. AMI-1 free acid is a potent, cell-permeable and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM and 3.0 μM for human PRMT1 and yeast-Hmt1p, respectively. AMI-1 free acid exerts PRMTs inhibitory effects by blocking peptide-substrate binding [1].
loading...
    loading...